Category Archives: TRIPS plus

The Trump Executive Order on drug prices: not what was promised nor needed, and contrary to US self interest

Source: Medium Emily Kopp has a big scoop for Kaiser Health News. She has obtained a six page document outlining the draft provisions or objectives of a proposed Presidential Executive Order (EO) on drug prices. She has shared some of … Continue reading

Posted in Compulsory Licensing, Data Exclusivity, Evergreening, IPR Enforcement, Special 301 report, Uncategorized, UNHLP report, US Pressure | Leave a comment

June 2017 Alert: Pressure on countries hiked by US on IP

The US government is stepping up on TRIPS plus pressure through bilateral forums based on a US law that passed under Obama to strengthen IPR enforcement and the 301 process. Countries targeted include India, Indonesia, China, Thailand, Ukraine in Asia … Continue reading

Posted in Compulsory Licensing, Data Exclusivity, Evergreening, IPR Enforcement, Special 301 report, Uncategorized, UNHLP report, US Pressure | Leave a comment

MSF criticizes Swiss pharma aims at upcoming India-EFTA trade talks

Source: Pharma Letter On May 30, 2017 (tomorrow), trade talks will resume for the India-EFTA (European Free Trade Association) free trade agreement (FTA) in Liechtenstein, between India and the EFTA countries of Switzerland, Norway, Iceland and Liechtenstein. Through this deal, … Continue reading

Posted in EFTA-India FTA, Evergreening, Patent, Uncategorized | Leave a comment

Pharmaceuticals & Patents, a talk by Justice Prabha Sridevan

  I am grateful to the Dr. N.S. Gopalakrishnan for inviting me to inaugurate this workshop, the theme being “Pharmaceuticals and patents.” This is a very important one today when there is a claim for a strong patent regime. But I must … Continue reading

Posted in Patent, TRIPS flexibilities, TRIPS plus, TRIPS&IP rights, Uncategorized, WTO | Leave a comment

Why RCEP is the problem, not the solution

Source: inquirer.net | May 17, 2017 On May 2-12, the 16 member-countries of the Regional Comprehensive Economic Partnership (RCEP) met in Manila for their 18th round of negotiations to craft a multilateral trade deal that would affect half of the world’s … Continue reading

Posted in Investor state dispute, IP Rights, ISDS, Regional Comprehensive Economic Partnership, TRIPS plus, TRIPS&IP rights, Uncategorized | Leave a comment

Oppose RCEP! Fight for Pro-People Trade!

People Over Profit Statement on the 18th Round of Negotiations of the Regional Comprehensive Economic Partnership (RCEP) in Manila, Philippines 10 May 2017 Amid growing dissent and discontent globally against neoliberal free trade and investment agreements (FTAs), trade negotiators from … Continue reading

Posted in ISDS, Regional Comprehensive Economic Partnership, TRIPS, TRIPS plus, Uncategorized | Leave a comment

Trade laws that rob common people

Dr Gopal Dabade, Deccan Herald|  May 8 2017 If the RCEP talks materialise, they will give big companies a market access to over 3 billion people. Trade between countries has existed since time immemorial. The World Tr­ade Organisation (WTO) is … Continue reading

Posted in Investor state dispute, IPR Enforcement, ISDS, Regional Comprehensive Economic Partnership, TRIPS plus, Uncategorized, WTO | Leave a comment